These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13340341)

  • 1. [Test of virulence of Salmonella paratyphi A on chick embryo: its use in serological protection of subjects immunized by anti-typho-paratyphoid vaccine].
    GRABAR J; LE MINOR S
    Ann Inst Pasteur (Paris); 1956 Jul; 91(1):117-20. PubMed ID: 13340341
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anti-Salmonella paratyphi B vaccination].
    Dimache G; Vlădoianu IR; Dimache V; Popescu P; Antonescu O; Mitrea D
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):477-86. PubMed ID: 4999244
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SERO-PROTECTION OF THE CHICK EMBRYO AGAINST SALMONELLA PARATYPHI A INFECTION. APPLICATION OF THE ASSAY OF VACCINES].
    VLADOIANU IR; DIMACHE G; POPESCO P; MEREUTA H; LOWE I; DINCOLESCO M; DIMACHE V
    Ann Inst Pasteur (Paris); 1965 Feb; 108():246-54. PubMed ID: 14305953
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH; Kantele JM; Kantele A
    Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A.
    Yin J; Cheng Z; Wu Y; He Q; Zhang J; Yang Z; Ding S; Li J; Guo D
    Microb Pathog; 2019 Dec; 137():103795. PubMed ID: 31610219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chick-embryo sero-protection test for evaluation of efficacy of the oral immunization by inactivated T.A.B. vaccine].
    Dimache G
    Ann Sclavo; 1972; 14(5):599-610. PubMed ID: 4669414
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
    Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
    Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the efficacy of oral typhoid vaccine in animal and man].
    Saletti M; Panero C; Genna G; Silli U
    Ann Sclavo; 1972; 14(5):611-9. PubMed ID: 4669415
    [No Abstract]   [Full Text] [Related]  

  • 16. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
    Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for typhoid fever and other salmonelloses.
    Martin LB
    Curr Opin Infect Dis; 2012 Oct; 25(5):489-99. PubMed ID: 22825288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is the oral typhoid-paratyphoid vaccination effective during an epidemic? Evaluation of a paratyphoid B epidemic in Bavaria, summer 1967].
    Freytag B; Koslik E; Marder E; Stickl H
    Dtsch Med Wochenschr; 1969 May; 94(19):990-5. PubMed ID: 4976271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complex experimental study on anti-Salmonella typhi vaccination. Protective property of human and rabbit serums for the mouse and chick embryo].
    Dimache G; Vladoianu IR; Dimache V; Popesco P
    Ann Inst Pasteur (Paris); 1971 Jun; 120(6):817-29. PubMed ID: 5557381
    [No Abstract]   [Full Text] [Related]  

  • 20. PARTIAL PURIFICATION OF THE "PROTECTIVE" ANTIGEN OF SALMONELLA TYPHIMURIUM AND ITS DISTRIBUTION AMONGST VARIOUS STRAINS OF BACTERIA.
    JENKIN CR; ROWLEY D
    Aust J Exp Biol Med Sci; 1965 Feb; 43():65-78. PubMed ID: 14269281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.